$ONT Cashflow Statement | Understand Stock

$ONT

$14.34 -$0.53 (3.56%) Close

$ONT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities:
Net loss
Adjustments to reconcile net loss to net cash provided by operating activities:
Provision (recovery) for credit loss
Depreciation and amortization
Non-cash leases expense
Stock-based compensation expense
Fair value changes in financial instruments
Fair value changes in business acquisition contingencies
Write off of deferred financing costs
Deferred income taxes
Amortization of deferred financing costs
Debt extinguishment costs
Other
Other operating activities, net

Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable and contract assets
Prepaid expenses and other current assets
Accounts payable and other accrued liabilities
Accrued payroll and benefits
Payment of contingent consideration
Change in operating leases
Other assets
Net cash provided by operating activities
Investing activities:
Proceeds from property insurance
Proceeds from corporate owned and property insurance
Purchases of property and equipment
Proceeds from the sale of property and equipment
Proprietary software development and other software costs
Payment of assumed purchase price obligations
Purchase price true ups
Minority investments
Cash paid for acquisitions, net of cash acquired
Net cash used in investing activities

Financing activities:
Proceeds from revolving line of credit
Repayment of the revolving line of credit
Proceeds from the aircraft loan
Repayment of aircraft loan
Proceeds from term loan
Repayment of term loan
Payment of contingent consideration and other purchase price true ups
Repayment of finance leases
Proceeds from issuance of common stock in public offerings, net of issuance costs
Payments of deferred financing costs
Debt issuance cost
Proceeds from issuance of common stock for exercised stock options
Proceeds from issuance of common stock in follow-on offering, net of issuance costs
Taxes paid related to net share settlement of equity awards
Proceeds from building sale leaseback
Dividend payment to the series A-2 stockholders
Repayment to the series A-2 stockholders
Redemption of series A-2 Preferred Stock
Net cash provided by (used in) financing activities

Change in cash, cash equivalents and restricted cash
Foreign exchange impact on cash balance
Cash, cash equivalents and restricted cash:
Beginning of year
End of year
Supplemental disclosures of cash flows information:
Cash paid for interest
Cash paid for income tax
Supplemental disclosures of non-cash investing and financing activities:
Property and equipment purchased under finance leases
Acquisitions unpaid contingent consideration
Acquisitions contingent consideration paid in common stock
Offering costs included in accounts payable and other accrued liabilities
Non-cash considerations received from sale of subsidiary
Accrued purchases of property and equipment
Common stock issued to acquire new businesses
Accrued lease surrender liability
Promissory note receivable issued in connection with the sale of assets of the Discontinued Specialty Lab

Comments